Memoquin acts as an acetylcholinesterase inhibitor, BACE1 inhibitor, and antioxidant, and it has been reported to improve scopolamine- and Aβ-induced cognitive impairment [32]. This evidence concerns the gene ACHE and Cognitive impairment.